1. Home
  2. CLAR vs CRDF Comparison

CLAR vs CRDF Comparison

Compare CLAR & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLAR
  • CRDF
  • Stock Information
  • Founded
  • CLAR 1957
  • CRDF 1999
  • Country
  • CLAR United States
  • CRDF United States
  • Employees
  • CLAR N/A
  • CRDF N/A
  • Industry
  • CLAR Recreational Games/Products/Toys
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLAR Consumer Discretionary
  • CRDF Health Care
  • Exchange
  • CLAR Nasdaq
  • CRDF Nasdaq
  • Market Cap
  • CLAR 139.4M
  • CRDF 144.4M
  • IPO Year
  • CLAR N/A
  • CRDF N/A
  • Fundamental
  • Price
  • CLAR $3.82
  • CRDF $2.02
  • Analyst Decision
  • CLAR Strong Buy
  • CRDF Strong Buy
  • Analyst Count
  • CLAR 3
  • CRDF 5
  • Target Price
  • CLAR $5.33
  • CRDF $11.10
  • AVG Volume (30 Days)
  • CLAR 93.0K
  • CRDF 1.1M
  • Earning Date
  • CLAR 11-06-2025
  • CRDF 11-06-2025
  • Dividend Yield
  • CLAR 2.62%
  • CRDF N/A
  • EPS Growth
  • CLAR N/A
  • CRDF N/A
  • EPS
  • CLAR N/A
  • CRDF N/A
  • Revenue
  • CLAR $254,200,000.00
  • CRDF $545,000.00
  • Revenue This Year
  • CLAR N/A
  • CRDF N/A
  • Revenue Next Year
  • CLAR $4.38
  • CRDF N/A
  • P/E Ratio
  • CLAR N/A
  • CRDF N/A
  • Revenue Growth
  • CLAR N/A
  • CRDF N/A
  • 52 Week Low
  • CLAR $3.02
  • CRDF $1.90
  • 52 Week High
  • CLAR $5.29
  • CRDF $5.64
  • Technical
  • Relative Strength Index (RSI)
  • CLAR 55.96
  • CRDF 35.33
  • Support Level
  • CLAR $3.45
  • CRDF $2.03
  • Resistance Level
  • CLAR $4.03
  • CRDF $2.27
  • Average True Range (ATR)
  • CLAR 0.13
  • CRDF 0.12
  • MACD
  • CLAR 0.02
  • CRDF 0.04
  • Stochastic Oscillator
  • CLAR 61.21
  • CRDF 31.08

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: